<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0122-0268</journal-id>
<journal-title><![CDATA[Revista MVZ Córdoba]]></journal-title>
<abbrev-journal-title><![CDATA[Rev.MVZ Cordoba]]></abbrev-journal-title>
<issn>0122-0268</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Córdoba - Facultad de Medicina Veterinaria y Zootecnia.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0122-02682010000200009</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Evaluación del hemograma en caninos sanos sometidos a la administracion de cisplatina]]></article-title>
<article-title xml:lang="en"><![CDATA[Evaluation of the hemogram in healthy canines under cisplatin therapy]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Calpa O]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Daleck]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Teotônio de Castro]]></surname>
<given-names><![CDATA[João]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Universidad de Nariño Facultad de Ciencias Pecuarias Departamento de Sanidad Animal]]></institution>
<addr-line><![CDATA[Pasto Nariño]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Universidad Estatal Paulista Facultad de Medicina Veterinaria y Zootecnia Servicio de Oncología Veterinaria]]></institution>
<addr-line><![CDATA[Jaboticabal Estado de São Paulo]]></addr-line>
<country>Brasil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>05</month>
<year>2010</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>05</month>
<year>2010</year>
</pub-date>
<volume>15</volume>
<numero>2</numero>
<fpage>2102</fpage>
<lpage>2110</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0122-02682010000200009&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0122-02682010000200009&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0122-02682010000200009&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Objetivo. Evaluar los valores medios del hemograma en perros sanos durante la quimioterapia con cisplatina. Materiales y métodos. Se evaluaron los parámetros del hemograma de ocho caninos sanos sometidos a terapia con cisplatina, distribuidos en dos grupos. A los perros del grupo uno se les administró cisplatina (70 mg/m², i.v.) y para prevenir la nefrotoxicidad recibieron suero fisiológico al 0.9% (25mL/kg/h, i.v.). Los animales del grupo dos no recibieron cisplatina. Resultados. El hemograma de los perros del grupo uno no mostró diferencia significativa (p>0.05) con respecto al de los animales del grupo dos. Conclusiones. Los datos obtenidos indicaron que el protocolo con cisplastina no alteró significativamente los valores medios del hemograma y el número de sesiones de quimioterapia aumenta el riesgo de disminución de los valores del hemograma.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Objective. To evaluate the average values of the hemogram test in healthy dogs during chemotherapy with cisplatin. Materials and methods. The hemogram parameters of eight healthy canines, which underwent therapy with cisplatin, were evaluated. These canines were divided into two groups. The dogs in the first group were given cisplatin (70mg/m², i.v.) and to prevent kidney poisoning they were given physiological serum at 0.9% (25mL/kg/h, i.v.). The dogs in group two were not given cisplatin. Results. The hemogram of the dogs in the first group did not show any significant difference (p>0.05) as compared to the dogs in group 2. Conclusions. The data obtained indicate the protocol used with cisplatine does not significantly alter the average values of the hemogram test and the number of chemotherapy sessions increases the risk of diminishing the values of the hemogram test.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Cisplatina]]></kwd>
<kwd lng="es"><![CDATA[quimioterapia]]></kwd>
<kwd lng="es"><![CDATA[hemograma]]></kwd>
<kwd lng="es"><![CDATA[hemoglobina]]></kwd>
<kwd lng="es"><![CDATA[leucocitos]]></kwd>
<kwd lng="es"><![CDATA[perros]]></kwd>
<kwd lng="en"><![CDATA[Cisplatin]]></kwd>
<kwd lng="en"><![CDATA[chemotherapy]]></kwd>
<kwd lng="en"><![CDATA[hemogram test]]></kwd>
<kwd lng="en"><![CDATA[haemoglobin]]></kwd>
<kwd lng="en"><![CDATA[white blood cells]]></kwd>
<kwd lng="en"><![CDATA[dogs]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[  ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Antunes]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Bianchi]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Antioxidantes da dieta como inibidores da nefrotoxicidade induzida pelo antitumoral cisplatina]]></article-title>
<source><![CDATA[Rev Nutri Campinas]]></source>
<year>2004</year>
<volume>17</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>89-96</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McKnight]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Principles of chemotherapy]]></article-title>
<source><![CDATA[Clin Tech in Small Animal Practice]]></source>
<year>2003</year>
<volume>18</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>67-72</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wallace]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Câncer drug pharmacology and clinical experience]]></article-title>
<source><![CDATA[Cancer in dogs and cats]]></source>
<year>2002</year>
<publisher-name><![CDATA[Teton NewMedia]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kochevar]]></surname>
<given-names><![CDATA[DT]]></given-names>
</name>
<name>
<surname><![CDATA[Mealey]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Principles of cancer chemotherapy]]></article-title>
<source><![CDATA[Vet Med]]></source>
<year>1997</year>
<volume>92</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>339-349</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barger]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Grindem]]></surname>
<given-names><![CDATA[CB]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Hematologic abnormalities associated with cancer therapy]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Feldman]]></surname>
<given-names><![CDATA[BF]]></given-names>
</name>
<name>
<surname><![CDATA[Zinkl]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Jain]]></surname>
<given-names><![CDATA[NC]]></given-names>
</name>
</person-group>
<source><![CDATA[Schalm's Veterinary Hematology]]></source>
<year>2000</year>
<edition>5</edition>
<publisher-name><![CDATA[Lippincott Williams å Wilkins]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schaeppi]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Heyman]]></surname>
<given-names><![CDATA[IA]]></given-names>
</name>
<name>
<surname><![CDATA[Fleischman]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenkrantz]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ilievski]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Phelan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cooney]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[D]]></surname>
<given-names><![CDATA[Ruth]]></given-names>
</name>
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cisplatina - dichlorodiammineplatinum (II) (NSC 119875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice]]></article-title>
<source><![CDATA[Tox Appl Pharm]]></source>
<year>1973</year>
<volume>25</volume>
<page-range>225-230</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[O'Keefe]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Harris]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Toxicology of oncologic drugs]]></article-title>
<source><![CDATA[Vet Clin North Am Small Anim Pract]]></source>
<year>1990</year>
<volume>20</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>483-504</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ogilvie]]></surname>
<given-names><![CDATA[GK]]></given-names>
</name>
<name>
<surname><![CDATA[Moore]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
</person-group>
<source><![CDATA[Managing the veterinary cancer patient]]></source>
<year>1995</year>
<publisher-loc><![CDATA[New Jersey ]]></publisher-loc>
<publisher-name><![CDATA[Veterinary learning systems company]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berg]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Canine Osteosarcoma: Amputation and chemotherapy]]></article-title>
<source><![CDATA[Vet Clin North Am Small Anim Pract]]></source>
<year>1996</year>
<volume>26</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>111-121</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bradelin]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
<name>
<surname><![CDATA[Mansour]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Al]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Agentes ameliorating or augmenting the nephrotoxicity of cisplatin]]></article-title>
<source><![CDATA[Food Chem Toxicol]]></source>
<year>2006</year>
<volume>44</volume>
<page-range>1173-1183</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dagli]]></surname>
<given-names><![CDATA[MLZ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Agentes Antineoplasicos]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Spinosa]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Górniak]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Bernardi]]></surname>
<given-names><![CDATA[M M]]></given-names>
</name>
</person-group>
<source><![CDATA[Farmacologia aplicada a medicina veterinária]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Rio de Janeiro ]]></publisher-loc>
<publisher-name><![CDATA[Guanabara Koogan]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Andrade]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Terapêutica antineoplasica]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Andrade]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
</person-group>
<source><![CDATA[Manual de terapêutica veterinária]]></source>
<year>2002</year>
<publisher-loc><![CDATA[São Paulo ]]></publisher-loc>
<publisher-name><![CDATA[ROCA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodaski]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[De Nardi]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Classificação dos quimioterápicos]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Rodaski]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[De Nardi]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
</person-group>
<source><![CDATA[Quimioterapia antineoplasica em cães e gatos]]></source>
<year>2006</year>
<publisher-loc><![CDATA[Curitiba ]]></publisher-loc>
<publisher-name><![CDATA[Bio Editora]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lanore]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Delprat]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Principais drogas]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Lanore]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Delprat]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Quimioterapia anticancerígena]]></source>
<year>2004</year>
<publisher-loc><![CDATA[São Paulo ]]></publisher-loc>
<publisher-name><![CDATA[ROCA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ogilvie]]></surname>
<given-names><![CDATA[GK]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Chemoterapy and the surgery patient: Principles and recent advances]]></article-title>
<source><![CDATA[Vet Clin North Am Small Anim Pract]]></source>
<year>1998</year>
<volume>13</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>22-32</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Song]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[MY]]></given-names>
</name>
<name>
<surname><![CDATA[Kang]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[YK]]></given-names>
</name>
<name>
<surname><![CDATA[Jung]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells.]]></article-title>
<source><![CDATA[Biochem Pharmacol]]></source>
<year>2001</year>
<volume>62</volume>
<page-range>1013-1023</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schalm]]></surname>
<given-names><![CDATA[OM]]></given-names>
</name>
<name>
<surname><![CDATA[Jain]]></surname>
<given-names><![CDATA[NC]]></given-names>
</name>
<name>
<surname><![CDATA[Carroll]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Veterinary Hematology]]></source>
<year>1975</year>
<edition>2</edition>
<publisher-loc><![CDATA[^ePhiladelphia Philadelphia]]></publisher-loc>
<publisher-name><![CDATA[WB Saunders]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bonassa]]></surname>
<given-names><![CDATA[EMA]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Conceitos gerais em quimioterapia antineoplásica]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Bonassa]]></surname>
<given-names><![CDATA[EMA]]></given-names>
</name>
</person-group>
<source><![CDATA[Enfermagem em quimioterapia]]></source>
<year>2000</year>
<publisher-loc><![CDATA[São Paulo ]]></publisher-loc>
<publisher-name><![CDATA[Editora Atheneu]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hoagland]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Hematologic complications of cancer chemotherapy]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Perry]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Yarbro]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
</person-group>
<source><![CDATA[Toxicity of chemotherapy]]></source>
<year>1984</year>
<publisher-loc><![CDATA[Orlando ]]></publisher-loc>
<publisher-name><![CDATA[Grune & Stratton]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giger]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<source><![CDATA[Oncologic emergencies in small animals. Part I. chemotherapy-related and hematologic emergencies]]></source>
<year>1984</year>
<volume>6</volume>
<page-range>689</page-range><publisher-name><![CDATA[Compendium]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hahn]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Hematologic changes associated with weekly low-dose ciaplatin adminitration in dogs]]></article-title>
<source><![CDATA[Vet Clin Pathol]]></source>
<year>1997</year>
<volume>26</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>29-31</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jain]]></surname>
<given-names><![CDATA[NC]]></given-names>
</name>
</person-group>
<source><![CDATA[Essentials of veterinary hematology. Comparative hematology of common domestic animals]]></source>
<year>1993</year>
<publisher-loc><![CDATA[^ePhiladelphia Philadelphia]]></publisher-loc>
<publisher-name><![CDATA[Lea & Febiger]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thrall]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<source><![CDATA[Hematologia e bioquímica clínica veterinária]]></source>
<year>2007</year>
<publisher-loc><![CDATA[São Paulo ]]></publisher-loc>
<publisher-name><![CDATA[Roca]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Beiguelman]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Análise de variância]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Beiguelman]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
</person-group>
<source><![CDATA[Curso practico de Bioestatística]]></source>
<year>2002</year>
<publisher-name><![CDATA[Ribeirão Preto: FUNPEC - Editora]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morrow]]></surname>
<given-names><![CDATA[GR]]></given-names>
</name>
<name>
<surname><![CDATA[Hickok]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenthal]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Progress in reducing nausea and emesis]]></article-title>
<source><![CDATA[Cancer]]></source>
<year>1995</year>
<volume>76</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>343-357</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dernell]]></surname>
<given-names><![CDATA[WS]]></given-names>
</name>
<name>
<surname><![CDATA[Rodney]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
<name>
<surname><![CDATA[Withrow]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Tumors of the Skeletal System]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Withrow]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[MacEwen]]></surname>
<given-names><![CDATA[EG]]></given-names>
</name>
</person-group>
<source><![CDATA[Small animal clinical oncology]]></source>
<year></year>
<page-range>2001</page-range><publisher-loc><![CDATA[^ePhiladelphia Philadelphia]]></publisher-loc>
<publisher-name><![CDATA[W.B. Saunders Company]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martins]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Daleck]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Calado]]></surname>
<given-names><![CDATA[EB]]></given-names>
</name>
<name>
<surname><![CDATA[Ziliotto]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Da Silva]]></surname>
<given-names><![CDATA[FMM]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Avaliação dos efeitos de dois protocolos para administração de cisplatina sobre a função renal de cães]]></article-title>
<source><![CDATA[Acta Cir Bras]]></source>
<year>2003</year>
<volume>18</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>314-319</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
